Rapid Recombinant Protein and Monoclonal Antibody Production
Small to large scale option using CHO, HEK293, and E.coli transgene expression systems
Leinco’s Novel Patent-Pending Mammalian Transgene Expression System
Developed for expediting the expression of recombinant proteins and monoclonal antibodies for use in early discovery research, preclinical trials or in vitro diagnostic procedures. This transgene expression system was developed to transfect mammalian cells such as Chinese Hamster Ovary (CHO) or HEK-293 cells with high efficiency during suspension cell culture in stirred tank bioreactors.
A Smart Economic Decision
Leinco Technologies’ methods for expediting recombinant protein and monoclonal antibody production may be a good economic decision in the preclinical discovery phase. In fact, it eliminates the expense and time associated with developing a stable cell line before the characteristics of the antibody are fully known. This method allows for the evaluation of antibody panels before moving forward with the establishment of a stable cell line. Mammalian expression systems also produce high purity recombinant proteins and monoclonal antibodies. This allows glycosylation and highly biologically active proteins with no need for refolding.
Protein-Free Cell Culture Media
Leinco utilizes a proprietary protein-free cell culture media formulation that is chemically defined animal origin free, as well as a serum-free based media called AlphaGrow™. The high efficiency of transfection contributes to high levels of protein expression achieved in Leinco Technologies’ transgene expression system.